Hepatic and Extrahepatic Colorectal Metastases Have Discordant Responses to Systemic Therapy. Pathology Data from Patients Undergoing Simultaneous Resection of Multiple Tumor Sites
Background: Systemic therapy is the standard treatment for patients with hepatic and extrahepatic colorectal metastases. It is assumed to have the same effectiveness on all disease foci, independent of the involved organ. The present study aims to compare the response rates of hepatic and extrahepat...
Main Authors: | Luca Vigano, Pio Corleone, Shadya Sara Darwish, Nicolò Turri, Simone Famularo, Lorenzo Viggiani, Lorenza Rimassa, Daniele Del Fabbro, Luca Di Tommaso, Guido Torzilli |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/3/464 |
Similar Items
-
Ablation therapy for patients with colorectal liver metastases with and without extrahepatic metastases: evaluation of long-term outcomes and prognostic factors
by: Jeanett Klubien, et al.
Published: (2023-07-01) -
Conventional Therapies Do Not Prolong the Prognosis of Hepatocellular Carcinoma Patients with Extrahepatic Metastases under Receiving of Tyrosine Kinase Inhibitors
by: Hiroshi Maeda, et al.
Published: (2022-01-01) -
Image-Guided Ablation Therapies for Extrahepatic Metastases from Hepatocellular Carcinoma: A Review
by: Noriyuki Umakoshi, et al.
Published: (2023-07-01) -
Epidemiological Study of New Cases of Peritoneal Metastases
by: YANG Rui, et al.
Published: (2022-11-01) -
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Metastases from Colorectal Cancer—An Overview of Current Status and Future Perspectives
by: Wilhelm Graf, et al.
Published: (2024-01-01)